News Daily News Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA Michael O'Riordan August 10, 2023
News Daily News FDA: Class I Recall for Left-Sided Impella Pumps Due to TAVI Interaction Caitlin E. Cox July 27, 2023
News Daily News PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains Shelley Wood June 22, 2023
News Daily News Journal Series Explores How Eroding Abortion Access Impacts the HF Community Todd Neale June 15, 2023
News Conference News TVT 2023 Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years Michael O'Riordan June 09, 2023
News Daily News Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs Shelley Wood March 31, 2023
News Daily News Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data Michael O'Riordan March 29, 2023
News Conference News THT 2023 TEER or VAD/Transplant in the Advanced HF Patient With MR? Shelley Wood March 20, 2023
News Daily News For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread Michael O'Riordan January 30, 2023
News Daily News New IABP Recall: Balloon Catheter Damage Might Cause Bleeding Into Pump Shelley Wood January 25, 2023
News Features Heart Failure Care Has a Pipeline Problem: What’s the Fix? Shelley Wood December 20, 2022
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Daily News US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution? Shelley Wood July 15, 2022
News Daily News Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach Michael O'Riordan June 21, 2022